Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00703963 · ClinicalTrials.gov registry record · NA
Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT00703963: Completed NA study, sponsored by Mayo Clinic.
NCT00703963 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00703963, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Patients who receive a mechanical heart valve to replace a diseased heart valve must take an anticoagulation medicine the rest of their lives, and monitor their level of anticoagulation. Until recently, the testing of the level of anticoagulation was performed at medical laboratories or hospitals. The purpose of this study is to see if patients who test their level of anticoagulation by themselves at home and then call their doctor with the result have better control of their anticoagulation as compared to patients whose anticoagulation is checked only by their physician.
Interventions
- OTHER Usual Care
- DEVICE INRatio monitor by Hemosense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00703963
The ClinicalTrials.gov registry entry for NCT00703963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00703963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00703963 about?
NCT00703963 is a clinical study titled "Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care". Patients who receive a mechanical heart valve to replace a diseased heart valve must take an anticoagulation medicine the rest of their lives, and monitor their level of anticoagulation. Until recently, the testing of the level of anticoagulation was performed at medical laboratories or hospitals. ...
What is the current status of trial NCT00703963?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2007-03. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00703963?
The interventions under investigation include: Usual Care (OTHER), INRatio monitor by Hemosense (DEVICE).
Who is sponsoring clinical trial NCT00703963?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.